After living with an enlarged prostate (BPH) for 10 years, Utah patient Steve Howlett found lasting relief through HoLEP ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Shorter hospitalization and lower transfusion rates seen with pulsed Thulium:YAG laser enucleation versus open simple ...

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

Charities have called for urgent action to make sure 'no patient is left confused, delayed or caught in the middle' as they ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

Findings from 14 studies involving more than 8,000 patients show Prolaris adds insight beyond conventional clinical risk categories ...

Canada: Researchers have found in a large, real-world multicenter cohort study that Rezūm water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) was associated with a low rate of ...

Real-world data reveal racial disparities in cancer pain medication timing and strong opioid prescribing, with gaps most pronounced in breast and prostate cancer. Patients from racially and ethnically ...